Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas A. Panella is active.

Publication


Featured researches published by Nicholas A. Panella.


Nature Genetics | 2007

A single positively selected West Nile viral mutation confers increased virogenesis in American crows

Aaron C. Brault; Claire Y.-H. Huang; Stanley A. Langevin; Richard M. Kinney; Richard A. Bowen; Wanichaya N. Ramey; Nicholas A. Panella; Edward C. Holmes; Ann M. Powers; Barry R. Miller

West Nile virus (WNV), first recognized in North America in 1999, has been responsible for the largest arboviral epiornitic and epidemic of human encephalitis in recorded history. Despite the well-described epidemiological patterns of WNV in North America, the basis for the emergence of WNV-associated avian pathology, particularly in the American crow (AMCR) sentinel species, and the large scale of the North American epidemic and epiornitic is uncertain. We report here that the introduction of a T249P amino acid substitution in the NS3 helicase (found in North American WNV) in a low-virulence strain was sufficient to generate a phenotype highly virulent to AMCRs. Furthermore, comparative sequence analyses of full-length WNV genomes demonstrated that the same site (NS3-249) was subject to adaptive evolution. These phenotypic and evolutionary results provide compelling evidence for the positive selection of a mutation encoding increased viremia potential and virulence in the AMCR sentinel bird species.


Emerging Infectious Diseases | 2004

Differential Virulence of West Nile Strains for American Crows

Aaron C. Brault; Stanley A. Langevin; Richard A. Bowen; Nicholas A. Panella; Brad J. Biggerstaff; Barry R. Miller; Nicholas Komar

Increased viremia and deaths in American Crows inoculated with a North American West Nile viral genotype indicate that viral genetic determinants enhance avian pathogenicity and increase transmission potential of WNV.


Journal of Medical Entomology | 2005

Use of Novel Compounds for Pest Control: Insecticidal and Acaricidal Activity of Essential Oil Components from Heartwood of Alaska Yellow Cedar

Nicholas A. Panella; Marc C. Dolan; Joseph J. Karchesy; Yeping Xiong; Javier Peralta-cruz; Mohammad A. Khasawneh; John A. Montenieri; Gary O. Maupin

Abstract Laboratory bioassays were conducted to determine the activity of 15 natural products isolated from essential oil components extracted from the heartwood of Alaska yellow cedar, Chamaecyparis nootkatensis (D. Don) Spach., against Ixodes scapularis Say nymphs, Xenopsylla cheopis (Rothchild), and Aedes aegypti (L.) adults. Four of the compounds from the essential oil have been identified as monoterpenes, five as eremophilane sesquiterpenes, five as eremophilane sesquiterpene derivatives from valencene and nootkatone, and one as a sesquiterpene outside the eremophilane parent group. Carvacrol was the only monoterpene that demonstrated biocidal activity against ticks, fleas, and mosquitoes with LC50 values after 24 h of 0.0068, 0.0059, and 0.0051% (wt:vol), respectively. Nootkatone from Alaska yellow cedar was the most effective of the eremophilane sesquiterpenes against ticks (LC50 = 0.0029%), whereas the nootkatone grapefruit extract exhibited the greatest biocidal activity against fleas (LC50 = 0.0029%). Mosquitoes were most susceptible to one of the derivatives of valencene, valencene-13-aldehyde (LC50 = 0.0024%), after 24 h. Bioassays to determine residual activity of the most effective products were conducted at 1, 2, 4, and 6 wk after initial treatment. Residual LC50 values for nootkatone did not differ significantly at 4 wk posttreatment from the observations made at the initial 24-h treatment. The ability of these natural products to kill arthropods at relatively low concentrations represents an alternative to the use of synthetic pesticides for control of disease vectors.


Ecohealth | 2006

Migrating Birds as Dispersal Vehicles for West Nile Virus

Jennifer C. Owen; Frank R. Moore; Nicholas A. Panella; Eric Edwards; Rachel Bru; Megan Hughes; Nicholas Komar

Whereas migrating birds have been implicated in the spread of West Nile virus (WNV), there is no direct evidence of birds actively migrating while infectious. The role of birds in WNV dispersal is difficult to assess in the field. However, this role can be evaluated experimentally because birds in migratory disposition display increased locomotor activity or restlessness under captive conditions. We tested the following hypotheses: (1) migrating passerine birds continue to exhibit migratory activity while infectious with WNV and (2) the migratory state of the individual affects the magnitude of viremia. We examined the migratory activity of two neoarctic-neotropical passerine migrants, Swainson’s thrush (Catharus ustulatus) and gray catbird (Dumetella carolinensis), during acute WNV infection. All gray catbirds and six of nine Swainson’s thrushes exhibited migratory activity while infectious. Moreover, migratory status did not appear to influence viremia titers, as might be expected if individuals were immunosuppressed during migration. Therefore, we demonstrate that migrating passerine birds are potential dispersal vehicles for WNV.


Journal of Medical Entomology | 2008

Culex Flavivirus Isolates from Mosquitoes in Guatemala

M. E. Morales-Betoulle; M. L. Monzón Pineda; S. M. Sosa; Nicholas A. Panella; C. Cordón-Rosales; Nicholas Komar; Ann M. Powers; B. W. Johnson

Abstract A new strain of Culex flavivirus (family Flaviviridae, genus Flavivirus, CxFV), an insect virus first described in Japan, was isolated from adult Culex quinquefasciatus Say (Diptera: Culicidae) collected in 2006 from Izabal Department on the Caribbean coast of Guatemala. Mosquito pools were assayed for flavivirus RNA by using flavivirus group-specific primers that amplified a 720-bp region of the nonstructural (NS) 5 gene by standard reverse transcriptase-polymerase chain reaction. From 210 pools (1,699 mosquitoes), eight tested positive, and six of these mosquito pools produced virus isolates in Aedes albopictus Skuse C6/36 cells. Nucleotide sequence comparison of the eight flavivirus RNA-positive pools showed that there was 100% identity among them, and phylogenetic analysis of the NS5 and envelope gene regions indicated that they represent a strain of the recently described CxFV from Japan. This is the first report of an insect flavivirus from Central America.


Journal of Medical Entomology | 2005

Bioecology and Vectorial Capacity of Aedes albopictus (Diptera: Culicidae) in Macao, China, in Relation to Dengue Virus Transmission

A. Paulo G. Almeida; Susana Baptista; Carla A. Sousa; M. Teresa Novo; Helena Da Cunha Ramos; Nicholas A. Panella; Marvin S. Godsey; M. João Simões; M. Luisa Anselmo; Nicholas Komar; Carl J. Mitchell; Henrique Ribeiro

Abstract Until 2001, the Chinese Territory of Macao had not registered any autochthonous dengue cases, despite the abundance of Aedes albopictus (Skuse), a known vector. This work describes a bioecological characterization of the local Ae. albopictus adult population, with the purpose of estimating the receptivity of Macao to dengue introduction. In the wet seasons of 1997 and 1998 and the dry season of 1998, Ae. albopictus was the most abundant human-biting mosquito. Daily biting rates of 314 mosquitoes per person were recorded in the wet season with a reduction to 94 in the dry season. Ae. albopictus was mainly exophagic and exophilic and had a human blood index of 44%. The parity rate of field-collected mosquitoes was 57%. Daily survival rate ranged from 91 to 97%. Estimates of vectorial capacity ranged from 144 to 880, depending on what parameter values were used. These estimates indicated a great receptivity for the introduction of dengue viruses, as the 2001 outbreak came to prove.


Journal of Clinical Microbiology | 2002

Detection of West Nile virus antigen in mosquitoes and avian tissues by a monoclonal antibody-based capture enzyme immunoassay.

Ann R. Hunt; Roy A. Hall; Amy J. Kerst; Roger S. Nasci; Harry M. Savage; Nicholas A. Panella; Kristy L. Gottfried; Kristen L. Burkhalter; John T. Roehrig

ABSTRACT An antigen capture immunoassay to detect West Nile (WN) virus antigen in infected mosquitoes and avian tissues has been developed. With this assay purified WN virus was detected at a concentration of 32 pg/0.1 ml, and antigen in infected suckling mouse brain and laboratory-infected mosquito pools could be detected when the WN virus titer was 102.1 to 103.7 PFU/0.1 ml. In a blindly coded set of field-collected mosquito pools (n = 100), this assay detected WN virus antigen in 12 of 18 (66.7%) TaqMan-positive pools, whereas traditional reverse transcriptase PCR detected 10 of 18 (55.5%) positive pools. A sample set of 73 organ homogenates from naturally infected American crows was also examined by WN virus antigen capture immunoassay and TaqMan for the presence of WN virus. The antigen capture assay detected antigen in 30 of 34 (88.2%) TaqMan-positive tissues. Based upon a TaqMan-generated standard curve of infectious WN virus, the limit of detection in the antigen capture assay for avian tissue homogenates was approximately 103 PFU/0.1 ml. The recommended WN virus antigen capture protocol, which includes a capture assay followed by a confirmatory inhibition assay used to retest presumptive positive samples, could distinguish between the closely related WN and St. Louis encephalitis viruses in virus-infected mosquito pools and avian tissues. Therefore, this immunoassay demonstrates adequate sensitivity and specificity for surveillance of WN virus activity in mosquito vectors and avian hosts, and, in addition, it is easy to perform and relatively inexpensive compared with the TaqMan assay.


Vector-borne and Zoonotic Diseases | 2001

Serologic Evidence for West Nile Virus Infection in Birds in Staten Island, New York, After an Outbreak in 2000

Nicholas Komar; Joseph E. Burns; Carrie Dean; Nicholas A. Panella; Stephen W. Dusza; Bryan Cherry

After an outbreak of West Nile virus (WNV) infections in people, horses, and wildlife in Staten Island, NY, during the summer of 2000, we surveyed the bird population of the island for evidence of infection. Neutralizing antibodies were detected in 59 of 257 (23.0%) resident birds and none of 96 transient (migrating) birds sampled in early October. Species with the greatest seroprevalence were northern cardinal (Cardinalis cardinalis) (69.2%) and rock dove (Columba livia) (54.5%). House sparrows (Passer domesticus) and chickens (Gallus gallus) had lower than expected seroprevalences, 8.6% and 5.5%, respectively. The geographic distribution of seropositivity suggested focal transmission at several locations on the island. The concentration of seropositive birds among resident bird populations on Staten Island supports the concept that many birds survive WNV infection and that some of these play an important role in the WNV-bird-mosquito transmission cycle.


Journal of Medical Entomology | 2000

La Crosse encephalitis virus habitat associations in Nicholas County, West Virginia.

Roger S. Nasci; Chester G. Moore; Brad J. Biggerstaff; Nicholas A. Panella; H. Q. Liu; Nick Karabatsos; Brent S. Davis; E. S. Brannon

Abstract Aedes triseriatus(Say) population density patterns and La Crosse encephalitis virus infection rates were evaluated in relation to a variety of habitat parameters over a 14-wk period. Ovitraps and landing collections were used in a La Crosse virus-enzootic area in Nicholas County, WV. Study sites were divided into categories by habitat type and by proximity to the residences of known La Crosse encephalitis cases. Results demonstrated thatAe. triseriatuspopulation densities were higher in sugar maple/red maple habitats than in hemlock/mixed hardwood habitats or in a site characterized by a large number of small red maple trees. Sites containing artificial containers had higher population densities than those without. La Crosse virus minimum infection rates in mosquitoes collected as eggs ranged from 0.4/1,000 to 7.5/1,000 in the 12 study sites, but did not differ significantly among sites regardless of habitat type or proximity to human case residences. La Crosse virus infection rates in landingAe. triseriatusmosquitoes ranged from 0.0/1,000 to 27.0/1,000. La Crosse virus was also isolated from host-seekingAe. canadensis(Theobald) in two study sites, at rates similar to those found in theAe. triseriatuspopulations. TheAe. triseriatusoviposition patterns and La Crosse virus infection rates suggest that this mosquito species disperses readily in the large woodlands of central West Virginia. The La Crosse enzootic habitats in Nicholas County, WV, are contrasted with those studied in other geographic regions where La Crosse virus is found.


Avian Diseases | 2007

DNA Vaccination of the American Crow (Corvus brachyrhynchos) Provides Partial Protection Against Lethal Challenge with West Nile Virus

Michel L. Bunning; Patricia E. Fox; Richard A. Bowen; Nicholas Komar; Gwong-Jen J. Chang; Tully Speaker; Michael R. Stephens; Nicole M. Nemeth; Nicholas A. Panella; Stanley A. Langevin; Paul Gordy; Max Teehee; Patricia R. Bright; Michael J. Turell

Abstract The New York 1999 strain of West Nile virus (WNV) is nearly 100% fatal in the American crow (Corvus brachyrhynchos). We evaluated four WNV vaccine formulations in American crows, including intramuscular (i.m.) DNA vaccine, i.m. DNA vaccine with adjuvant, orally administered microencapsulated DNA vaccine, and i.m. killed vaccine. Neutralizing antibodies developed in approximately 80% of crows that received the DNA vaccine i.m. (with or without adjuvant), and in 44% that received the killed vaccine. However, no crows that received the oral microencapsulated DNA vaccine or the placebo developed WNV antibodies. All crows were challenged 10 wk after initial vaccination. No unvaccinated crows survived challenge, and survival rates were 44% (i.m. DNA vaccine), 60% (i.m. DNA vaccine with adjuvant), 0% (oral microencapsulated DNA vaccine), and 11% (killed vaccine). Peak viremia titers in the birds that survived were significantly lower as compared to titers in birds that died. Parenteral administration of a WNV DNA vaccine was associated with reduced mortality but did not provide sterile immunity.

Collaboration


Dive into the Nicholas A. Panella's collaboration.

Top Co-Authors

Avatar

Nicholas Komar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Kristen L. Burkhalter

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Marc C. Dolan

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Marvin S. Godsey

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Gary O. Maupin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Harry M. Savage

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Aaron C. Brault

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brad J. Biggerstaff

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Roger S. Nasci

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge